Cantor Fitzgerald reiterated its Overweight rating on Centene on Monday. A Seeking Alpha analysis simultaneously published a bullish thesis for the insurer. Analysts expect a recovery in the ACA marketplace and favorable 2026 Medicare adjustments to lower the Health Benefits Ratio.
Cantor Fitzgerald views recent Medicaid membership attrition as consistent with Centene’s annual outlook. The company added 42,000 new enrollees in the second quarter following UnitedHealth’s contract termination in Louisiana. Louisiana will establish new reimbursement rates on July 1, 2026.
Seeking Alpha projects a 30% share price upside to $87 within 18 months. This forecast assumes Centene reaches an estimated $4.50 EPS while maintaining its current P/E ratio. The report characterizes 2025 challenges as industry-wide rather than company-specific.